Possible risk factors identified for VTE during stem cell transplant

Key, Nigel
September 2008
Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p20
The article reports on a study which examined risk factors for the development of venous thromboembolism (VTE) in patients undergoing hematopoietic stem cell transplantation and for bleeding among patients who did not receive VTE prophylaxis prior to receiving inpatient stem cell transplants. Researchers from the U.S. concluded that prior VTE and development of graft-versus-host disease were significant risk factors for (VTE) in patients undergoing hematopoietic stem cell transplantation.


Related Articles

  • Childhood HSCT increased risk for kidney stones.  // Hem/Onc Today;1/10/2014, Vol. 15 Issue 1, p21 

    The article discusses the retrospective study that found an increased risk of kidney stone development in patients who received hematopoietic stem cell transplantation (HSCT) as part of childhood cancer treatment, when they become adults.

  • Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Gordon, B; Tarantolo, S; Ruby, E; Stephens, L; Lynch, J; Kessinger, A; Haire, W // Bone Marrow Transplantation;11/15/98, Vol. 22 Issue 10, p999 

    Organ dysfunction following hematopoietic stem cell transplantation (HSCT) may be a manifestation of a systemic inflammatory response. We speculate that part of the platelet transfusion requirement in HSCT patients results from this systemic inflammatory response, and increased transfusion...

  • Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Lee, J. W.; Kang, H. J.; Kim, E. K.; Kim, H.; Shin, H. Y.; Ahn, H. S. // Bone Marrow Transplantation;Dec2009, Vol. 44 Issue 12, p793 

    Iron overload is known to increase complications of hematopoietic SCT (HSCT). We investigated the association of pre-transplant ferritin level with complications and survival after allogeneic HSCT, and evaluated the efficacy of iron-chelating therapy before HSCT. We retrospectively reviewed 101...

  • Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Gea-Banacloche, J; Masur, H; da Cunha, C Arns; Chiller, T; Kirchhoff, L V; Shaw, P; Tomblyn, M; Cordonnier, C // Bone Marrow Transplantation;Apr2010, Vol. 45 Issue 4, p806 

    A correction to the article "Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective" that was published in 2009 issue is presented.

  • Risk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children. You Jin Jung; Yeon Jin Jeon; Won Kyoung Cho; Jae Wook Lee; Nack-Gyun Chung; Min Ho Jung; Bin Cho; Byung-Kyu Suh // Korean Journal of Pediatrics;Jul2013, Vol. 56 Issue 7, p298 

    Purpose: The purpose of this study was to evaluate short-term thyroid dysfunction and related risk factors in pediatric patients who underwent hematopoietic stem cell transplantation (HSCT) during childhood. Methods: We studied 166 patients (100 boys and 66 girls) who underwent HSCT at the...

  • Graft failure in the modern era of allogeneic hematopoietic SCT. Olsson, R; Remberger, M; Schaffer, M; Berggren, D M; Svahn, B-M; Mattsson, J; Ringden, O // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p537 

    Graft failure may contribute to increased morbidity and mortality after allogeneic hematopoietic SCT (allo-HSCT). Here, we present risk factors for graft failure in all first allo-HSCTs performed at our center from 1995 to mid-2010 (n=967). Graft failure was defined as >95% recipient cells any...

  • Accuracy of self-reported tobacco use status among hematopoietic SCT patients. Ehlers, S L; Bronars, C A; Patten, C A; Brockman, T; Hughes, C; Decker, P A; Cerhan, J R; Hogan, W; Dispenzieri, A; Ansell, S; Ebbert, J; Gastineau, D // Bone Marrow Transplantation;Jul2014, Vol. 49 Issue 7, p961 

    Tobacco use is a risk factor for adverse outcomes among hematopoietic SCT (HSCT) patients. Accurate identification of tobacco use offers a vital opportunity to treat this risk factor. The current study compared self-reported tobacco use status with serum cotinine levels among HSCT patients at...

  • The EBMT risk score. Gratwohl, A // Bone Marrow Transplantation;Jun2012, Vol. 47 Issue 6, p749 

    The European Group for Blood and Marrow Transplantation (EBMT) risk score provides a simple tool to assess instantly chances and risks of hematopoietic SCT(HSCT) for an individual patient pre-transplant. Five factors, age of the patient, stage of the disease, time from diagnosis, donor type and...

  • Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies. VanderWalde, A M; Sun, C-L; Laddaran, L; Francisco, L; Armenian, S; Berano-Teh, J; Wong, F L; Popplewell, L; Somlo, G; Stein, A S; Nademanee, A; Krishnan, A; Kogut, N; Forman, S J; Bhatia, S // Leukemia (08876924);May2013, Vol. 27 Issue 5, p1139 

    The probability of survival is conventionally calculated from autologous hematopoietic cell transplantation (aHCT). Conditional survival takes into account the changing probability of survival with time survived, but this is not known for aHCT populations. We determined disease- and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics